If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Quality, Compliance and Regulatory » Government Affairs and Public Policy
Excerpt in Cart
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Non-members: Click here to sign-up for a complimentary tour of
"U.S. Pharmaceutical State Government Affairs: Benchmarking the Resources Required to Ensure Brand Market Access"
With pricing, political, regulatory and marketing pressures at an all-time high, State Government Affairs functions in the pharmaceutical and biotechnology industries with operations in the U.S. market are continually reassessing levels of human and capital investment needed to support their organizations. Few if any companies can afford not to pay attention to how many people it staffs or how much it invests in this critical function. This benchmarking study was designed to help provide pharmaceutical and biotech State Government Affairs executives and managers that work in the US market assess their investment levels compared to others.
For the purposes of this study, State Government Affairs includes the following activities:
Pharmaceutical; Medical Device; Biotech; Health Care
GlaxoSmithKline; Elli Lilly; Roche; Bristol-Myers Squibb; Boehringer Ingelheim; Merck; MedImmune